Camille L. Bedrosian, EVP and Chief Medical Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 7,762 shares at $45.25 ($351K) on 2023-03-01, disclosed to the SEC on 2023-03-03.
Seasonal sale ($351k) by EVP and Chief Medical Officer — this insider has traded RARE in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.25 | 3,881 | $176K | 50.0% |
| 2 | $45.25 | 3,881 | $176K | 50.0% |
| Total | $45.25 avg | 7,762 | $351K | 100% |
| Filing → |
| AMLX | SELL | 2025-12-03 | $94K | — | Filing → |
| AMLX | SELL | 2025-10-02 | $351K | — | Filing → |
| AMLX | SELL | 2025-04-02 | $43K | — | Filing → |